Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18306112 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TDP1CYP3A4ALOX15LMNA | |
| SCHEMBL4960492 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TDP1CYP3A4ALOX15LMNA | |
| SCHEMBL26658590 | 0.81 | ALDH1A1 (0.57) | ALDH1A1TDP1CYP3A4ALOX15KEAP1 | |
| SCHEMBL4849341 | 0.81 | DTYMK (0.47) | ALDH1A1TDP1CYP3A4ALOX15LMNA | |
| SCHEMBL15962080 | 0.81 | TDP1 (0.57) | ALDH1A1TDP1CYP3A4ALOX15KEAP1 | |
| SCHEMBL25294147 | 0.79 | ALDH1A1 (0.40) | ALDH1A1TDP1CYP3A4ALOX15LMNA | |
| SCHEMBL17688824 | 0.79 | ALDH1A1 (0.46) | ALDH1A1TDP1CYP3A4ALOX15MAPT | |
| SCHEMBL3342909 | 0.79 | ALDH1A1 (0.41) | ALDH1A1TDP1CYP3A4ALOX15LMNA | |
| SCHEMBL2427891 | 0.79 | ALDH1A1 (0.56) | ALDH1A1TDP1CYP3A4ALOX15KEAP1 | |
| SCHEMBL22288521 | 0.79 | MEN1 (0.46) | ALDH1A1TDP1CYP3A4ALOX15KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080207635-A1 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders | CHEMBRIDGE CORPORATION | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207635-A1 | Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders | LCK, MALT1, MYD88 | ALDH1A1 2293/4885TDP1 1277/4885CYP3A4 2763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.